Rgs9-2–controlled Adaptations in the Striatum Determine the Onset of Action and Efficacy of Antidepressants in Neuropathic Pain States Accessed Terms of Use Detailed Terms

Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters.

[1]  G. Descalzi,et al.  RGS9-2 modulates sensory and mood related symptoms of neuropathic pain , 2014, Neurobiology of Learning and Memory.

[2]  M. Barrot,et al.  The anxiodepressive comorbidity in chronic pain , 2014, Current opinion in anaesthesiology.

[3]  R. Huganir,et al.  GluA1 Phosphorylation Contributes to Postsynaptic Amplification of Neuropathic Pain in the Insular Cortex , 2014, The Journal of Neuroscience.

[4]  B. Lim,et al.  Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens , 2014, Science.

[5]  Massimo Contini,et al.  Role of nucleus accumbens in neuropathic pain: Linked multi-scale evidence in the rat transitioning to neuropathic pain , 2014, PAIN®.

[6]  E. Capobianco,et al.  Identification of potential therapeutic targets in a model of neuropathic pain , 2014, Front. Genet..

[7]  E. Nestler,et al.  Prefrontal Cortical Circuit for Depression- and Anxiety-Related Behaviors Mediated by Cholecystokinin: Role of ΔFosB , 2014, The Journal of Neuroscience.

[8]  K. Deisseroth,et al.  Nucleus Accumbens-Specific Interventions in RGS9-2 Activity Modulate Responses to Morphine , 2014, Neuropsychopharmacology.

[9]  N. Attal,et al.  Psychiatric co‐morbidities in patients with chronic peripheral neuropathic pain: A multicentre cohort study , 2013, European journal of pain.

[10]  L. Becerra,et al.  Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans. , 2013, Journal of neurophysiology.

[11]  Xue-Jun Song,et al.  WNT signaling underlies the pathogenesis of neuropathic pain in rodents. , 2013, The Journal of clinical investigation.

[12]  E. Nestler,et al.  Regulator of G protein signaling 4 is a crucial modulator of antidepressant drug action in depression and neuropathic pain models , 2013, Proceedings of the National Academy of Sciences.

[13]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[14]  Z. Duan,et al.  Interaction of G-Protein βγ Complex with Chromatin Modulates GPCR-Dependent Gene Regulation , 2013, PloS one.

[15]  David G Hendrickson,et al.  Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.

[16]  Yoko Furukawa-Hibi,et al.  Transcriptional suppression of the neuronal PAS domain 4 (Npas4) gene by stress via the binding of agonist‐bound glucocorticoid receptor to its promoter , 2012, Journal of neurochemistry.

[17]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[18]  A. Abdel-Zaher,et al.  Comparative evaluation of the effect of tricyclic antidepressants on inducible nitric oxide synthase expression in neuropathic pain model. , 2012, Nitric oxide : biology and chemistry.

[19]  J. Micó,et al.  Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: Implications for neuropathic pain , 2012, PAIN.

[20]  Nanxin Li,et al.  Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stress , 2012, Proceedings of the National Academy of Sciences.

[21]  Ralf Baron,et al.  Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms , 2012, Neuron.

[22]  R. Neve,et al.  Histone Deacetylase 5 Limits Cocaine Reward through cAMP-Induced Nuclear Import , 2012, Neuron.

[23]  Yunjia Chen,et al.  The Antidepressant Desipramine Is an Arrestin-biased Ligand at the α2A-Adrenergic Receptor Driving Receptor Down-regulation in Vitro and in Vivo* , 2011, The Journal of Biological Chemistry.

[24]  D. Ferguson,et al.  A Unique Role of RGS9-2 in the Striatum as a Positive or Negative Regulator of Opiate Analgesia , 2011, The Journal of Neuroscience.

[25]  A. Vania Apkarian,et al.  Pain and the brain: Specificity and plasticity of the brain in clinical chronic pain , 2011, PAIN.

[26]  José María Delgado-García,et al.  Associative Learning and CA3–CA1 Synaptic Plasticity Are Impaired in D1R Null, Drd1a−/− Mice and in Hippocampal siRNA Silenced Drd1a Mice , 2010, The Journal of Neuroscience.

[27]  Cristina Murga,et al.  The complex G protein‐coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets , 2010, British journal of pharmacology.

[28]  Román A. Corfas,et al.  Loss of Inhibitory Interneurons in the Dorsal Spinal Cord and Elevated Itch in Bhlhb5 Mutant Mice , 2010, Neuron.

[29]  R. Hashimoto,et al.  Depression‐like behavior in the forced swimming test in PACAP‐deficient mice: amelioration by the atypical antipsychotic risperidone , 2009, Journal of neurochemistry.

[30]  J. O'Donnell,et al.  Postsynaptic α-2 Adrenergic Receptors are Critical for the Antidepressant-Like Effects of Desipramine on Behavior , 2009, Neuropsychopharmacology.

[31]  J. Traynor,et al.  RGS9-2: probing an intracellular modulator of behavior as a drug target. , 2009, Trends in pharmacological sciences.

[32]  M. Barrot,et al.  β2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain , 2009, Neurobiology of Disease.

[33]  M. L. Macdonald,et al.  Desipramine Reduces Stress-Activated Dynorphin Expression and CREB Phosphorylation in NAc Tissue , 2009, Molecular Pharmacology.

[34]  Deanna L. Wallace,et al.  CREB regulation of nucleus accumbens excitability mediates social isolation–induced behavioral deficits , 2009, Nature Neuroscience.

[35]  P. Greengard,et al.  Cocaine Regulates MEF2 to Control Synaptic and Behavioral Plasticity , 2008, Neuron.

[36]  N. Gardiner,et al.  Neuritin Mediates Nerve Growth Factor–Induced Axonal Regeneration and Is Deficient in Experimental Diabetic Neuropathy , 2008, Diabetes.

[37]  Guanghua Xiao,et al.  Histone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli , 2007, Neuron.

[38]  G. Cruccu.  Treatment of painful neuropathy , 2007, Current opinion in neurology.

[39]  E. Nestler,et al.  The Mesolimbic Dopamine Reward Circuit in Depression , 2006, Biological Psychiatry.

[40]  J. Blendy.  The Role of CREB in Depression and Antidepressant Treatment , 2006, Biological Psychiatry.

[41]  M. Picciotto,et al.  Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction? , 2006, CNS & neurological disorders drug targets.

[42]  J. Blendy,et al.  Antidepressant action: to the nucleus and beyond. , 2005, Trends in pharmacological sciences.

[43]  M. Narita,et al.  Direct evidence for the involvement of brain‐derived neurotrophic factor in the development of a neuropathic pain‐like state in mice , 2005, Journal of neurochemistry.

[44]  Johannes Schwarz,et al.  D2 Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways , 2005, The Journal of Neuroscience.

[45]  S. Sands,et al.  Relationship between the antinociceptive response to desipramine and changes in GABAB receptor function and subunit expression in the dorsal horn of the rat spinal cord. , 2004, Biochemical pharmacology.

[46]  W. Katon,et al.  Depression and pain comorbidity: a literature review. , 2003, Archives of internal medicine.

[47]  E. Nestler,et al.  Essential role for RGS9 in opiate action , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Basbaum,et al.  Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis. , 2003, The journal of pain : official journal of the American Pain Society.

[49]  V. Pachnis,et al.  Transgenic overexpression of galanin in the dorsal root ganglia modulates pain-related behavior , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Bading,et al.  Neuronal activity‐dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5 , 2003, Journal of neurochemistry.

[51]  M. Zhuo,et al.  Genetic Elimination of Behavioral Sensitization in Mice Lacking Calmodulin-Stimulated Adenylyl Cyclases , 2002, Neuron.

[52]  R. Quirion,et al.  The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test , 2002, Neuropsychopharmacology.

[53]  Feng juan Wei,et al.  Oxytocin mediates stress‐induced analgesia in adult mice , 2002, The Journal of physiology.

[54]  E. Olson,et al.  Identification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases , 2001, Molecular and Cellular Biology.

[55]  P. Ernfors,et al.  Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor , 2001, Nature.

[56]  R. Stoffel,et al.  Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Huganir,et al.  Characterization of Multiple Phosphorylation Sites on the AMPA Receptor GluR1 Subunit , 1996, Neuron.

[58]  R. Dubner,et al.  Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial , 1991, Pain.

[59]  K. Blumer,et al.  R9AP and R7BP: traffic cops for the RGS7 family in phototransduction and neuronal GPCR signaling. , 2009, Trends in pharmacological sciences.

[60]  H. Hamm,et al.  G betagamma binds histone deacetylase 5 (HDAC5) and inhibits its transcriptional co-repression activity. , 2005, The Journal of biological chemistry.

[61]  S. Matsumura,et al.  Development / Plasticity / Repair Pituitary Adenylate Cyclase-Activating Polypeptide Is Required for the Development of Spinal Sensitization and Induction of Neuropathic Pain , 2004 .

[62]  G. Reynolds,et al.  Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. , 2003, Oncogene.

[63]  J. Sondek,et al.  Ggamma-like (GGL) domains: new frontiers in G-protein signaling and beta-propeller scaffolding. , 2001, Biochemical pharmacology.